Stockholders' Equity (Details) - Schedule of restricted stock shares granted and outstanding - USD ($) |
3 Months Ended | 12 Months Ended |
|---|---|---|
Mar. 31, 2023 |
Dec. 31, 2022 |
|
| Schedule Of Restricted Stock Shares Granted And Outstanding Abstract | ||
| Unvested Restricted Stock, Unvested Beginning | 275 | |
| Weighted Average Grant Date FV Price, Unvested Beginning | $ 81 | |
| Unvested Restricted Stock, Granted | 600 | |
| Weighted Average Grant Date FV Price, Granted | $ 81 | |
| Unvested Restricted Stock, Vested | 100 | 325 |
| Weighted Average Grant Date FV Price, Vested | $ 81 | $ 81 |
| Unvested Restricted Stock, Unvested Ending | 120 | 275 |
| Weighted Average Grant Date FV Price, Unvested Ending | $ 81 | $ 81 |
| Unvested Restricted Stock, Total unrecognized expense remaining | $ 9,720 | $ 22,275,000,000 |
| Unvested Restricted Stock, Weighted-average years expected to be recognized over | 9 months | 1 year |
| Weighted Average Grant Date FV Price, Weighted-average years expected to be recognized over |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount, after tax, of expense for award under share-based payment arrangement. No definition available.
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Net number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|